Compare DHY & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DHY | TNYA |
|---|---|---|
| Founded | 1998 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 207.2M | 234.8M |
| IPO Year | N/A | 2021 |
| Metric | DHY | TNYA |
|---|---|---|
| Price | $2.00 | $0.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $7.80 |
| AVG Volume (30 Days) | 569.1K | ★ 7.7M |
| Earning Date | 01-01-0001 | 11-10-2025 |
| Dividend Yield | ★ 9.10% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.77 | $0.36 |
| 52 Week High | $2.08 | $2.35 |
| Indicator | DHY | TNYA |
|---|---|---|
| Relative Strength Index (RSI) | 46.57 | 34.74 |
| Support Level | $1.98 | $0.68 |
| Resistance Level | $2.03 | $0.76 |
| Average True Range (ATR) | 0.02 | 0.08 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 49.67 | 20.61 |
Credit Suisse High Yield Bond Fund is a non-diversified, closed-end management investment company to seeks high current income and capital appreciation as a secondary objective.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.